CMMB — Chemomab Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Chemomab Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.7	61.2	39.9	19.8	14.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11.8	62.7	41.7	20.9	16
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.58	0.702	0.594	0.695	0.539
Other Long Term Assets
Total Assets	12.5	64.4	43.1	22.2	17
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.32	2.65	6.75	4.84	3.22
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.67	2.89	6.84	5.15	3.43
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	10.8	61.5	36.2	17	13.5
Total Liabilities & Shareholders' Equity	12.5	64.4	43.1	22.2	17
Total Common Shares Outstanding